Cargando…

Geo-prioritization framework for COVID-19 vaccine allocation in India

Up until now, countries have adopted a ‘isolate-test-treat-trace’ strategy to contain the COVID-19 pandemic. The next critical intervention in the fight against COVID-19 will be effective delivery of safe and efficacious vaccines. Various countries such as the USA, the UK, Canada, Israel, etc., have...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahajan, Akshay, Kaur, Jasmine, Sidana, Chirag, Shivam, Shashwat, Singh, Harpreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324408/
https://www.ncbi.nlm.nih.gov/pubmed/34364717
http://dx.doi.org/10.1016/j.vaccine.2021.07.084
_version_ 1783731390345379840
author Mahajan, Akshay
Kaur, Jasmine
Sidana, Chirag
Shivam, Shashwat
Singh, Harpreet
author_facet Mahajan, Akshay
Kaur, Jasmine
Sidana, Chirag
Shivam, Shashwat
Singh, Harpreet
author_sort Mahajan, Akshay
collection PubMed
description Up until now, countries have adopted a ‘isolate-test-treat-trace’ strategy to contain the COVID-19 pandemic. The next critical intervention in the fight against COVID-19 will be effective delivery of safe and efficacious vaccines. Various countries such as the USA, the UK, Canada, Israel, etc., have started administering vaccines to priority population groups. India is gearing up its critical components of the vaccine delivery system to effectively deliver vaccines across the country and has prioritized certain population groups to whom the vaccine will be administered. Considering India’s ambitious target to vaccinate close to 300 million people in the first phase of the vaccination drive with limited initial supply (which will be ramped up gradually), it is critical for stakeholders at all the levels – national, state and district – to understand the estimated need for vaccines across geographies based on the vulnerable population and disease epidemiology with the objective of preventing maximum number of future infections from the disease. This paper aims to describe a comprehensive geo-prioritization framework based on existing prevalence of COVID-19, high-risk co-morbidities, and demographic analysis to identify states/districts that could be most in need of the COVID-19 vaccines.
format Online
Article
Text
id pubmed-8324408
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-83244082021-08-02 Geo-prioritization framework for COVID-19 vaccine allocation in India Mahajan, Akshay Kaur, Jasmine Sidana, Chirag Shivam, Shashwat Singh, Harpreet Vaccine Commentary Up until now, countries have adopted a ‘isolate-test-treat-trace’ strategy to contain the COVID-19 pandemic. The next critical intervention in the fight against COVID-19 will be effective delivery of safe and efficacious vaccines. Various countries such as the USA, the UK, Canada, Israel, etc., have started administering vaccines to priority population groups. India is gearing up its critical components of the vaccine delivery system to effectively deliver vaccines across the country and has prioritized certain population groups to whom the vaccine will be administered. Considering India’s ambitious target to vaccinate close to 300 million people in the first phase of the vaccination drive with limited initial supply (which will be ramped up gradually), it is critical for stakeholders at all the levels – national, state and district – to understand the estimated need for vaccines across geographies based on the vulnerable population and disease epidemiology with the objective of preventing maximum number of future infections from the disease. This paper aims to describe a comprehensive geo-prioritization framework based on existing prevalence of COVID-19, high-risk co-morbidities, and demographic analysis to identify states/districts that could be most in need of the COVID-19 vaccines. Published by Elsevier Ltd. 2021-08-31 2021-07-31 /pmc/articles/PMC8324408/ /pubmed/34364717 http://dx.doi.org/10.1016/j.vaccine.2021.07.084 Text en © 2021 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Mahajan, Akshay
Kaur, Jasmine
Sidana, Chirag
Shivam, Shashwat
Singh, Harpreet
Geo-prioritization framework for COVID-19 vaccine allocation in India
title Geo-prioritization framework for COVID-19 vaccine allocation in India
title_full Geo-prioritization framework for COVID-19 vaccine allocation in India
title_fullStr Geo-prioritization framework for COVID-19 vaccine allocation in India
title_full_unstemmed Geo-prioritization framework for COVID-19 vaccine allocation in India
title_short Geo-prioritization framework for COVID-19 vaccine allocation in India
title_sort geo-prioritization framework for covid-19 vaccine allocation in india
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324408/
https://www.ncbi.nlm.nih.gov/pubmed/34364717
http://dx.doi.org/10.1016/j.vaccine.2021.07.084
work_keys_str_mv AT mahajanakshay geoprioritizationframeworkforcovid19vaccineallocationinindia
AT kaurjasmine geoprioritizationframeworkforcovid19vaccineallocationinindia
AT sidanachirag geoprioritizationframeworkforcovid19vaccineallocationinindia
AT shivamshashwat geoprioritizationframeworkforcovid19vaccineallocationinindia
AT singhharpreet geoprioritizationframeworkforcovid19vaccineallocationinindia